Previous 10 | Next 10 |
Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics PR Newswire NORWOOD, Mass. , Sept. 19, 2023 /PRNewswire/ -- Corbus Phar...
2023-08-08 09:02:34 ET Corbus Pharmaceuticals press release ( NASDAQ: CRBP ): Q2 GAAP EPS of -$2.05. As of June 30, 2023, the company has $36.6 million of cash, cash equivalents and investments on hand which is expected to fund operations through the second quarter of 20...
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire CRB-701 Phase 1 trial in China is ahead of schedule with dose escalation completion expected Q4 2023 and U.S. clinical trial start planned for Q1 2024 P...
2023-08-04 13:07:47 ET Summary Corbus Pharmaceuticals is shifting its strategy after the Lenabasum failure, focusing on new drugs CRB-601 & CRB-701. Despite a healthy balance sheet, Corbus' cash reserves are steadily depleting, especially when the company has generated no reve...
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference PR Newswire NORWOOD, Mass. , July 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today an...
2023-06-26 10:23:21 ET Corbus Pharmaceuticals Holdings ( NASDAQ: CRBP ) has joined Russell Microcap Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today. CRBP is -10.1% to $7.9 Source: Press Release ...
Corbus Pharmaceuticals Set to Join Russell Microcap® Index PR Newswire NORWOOD, Mass. , June 26, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that the Com...
2023-05-31 10:05:20 ET Gainers: Marker Therapeutics ( MRKR ) +34% . Nano-X Imaging ( NNOX ) +13% . Zai Lab ( ZLAB ) +9% . Invivyd ( IVVD ) +8% . Corbus Pharmaceuticals ( CRBP ) +7% . Losers: Belite Bio ( BLTE ) ...
Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference PR Newswire NORWOOD, Mass. , May 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today annou...
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...